HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melanie Ziman Selected Research

trametinib

12/2015Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Melanie Ziman Research Topics

Disease

17Melanoma (Melanoma, Malignant)
12/2020 - 09/2012
11Neoplasms (Cancer)
10/2020 - 02/2010
4Circulating Neoplastic Cells
01/2020 - 12/2018
2Uveal melanoma
12/2020 - 11/2019
2Disease Progression
11/2020 - 01/2020
1Myositis (Idiopathic Inflammatory Myopathies)
12/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Nevus (Nevi)
11/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2019
1Carcinogenesis
01/2019
1Breast Neoplasms (Breast Cancer)
02/2010
1Arthritis (Polyarthritis)
05/2009
1Rheumatoid Arthritis
05/2009
1Ectromelia (Phocomelia)
04/2009
1Infectious Ectromelia
04/2009
1Infections
03/2008
1Tuberculosis (Tuberculoses)
03/2008
1T-Cell Leukemia (Leukemia, T Cell)
04/2006
1Diarrhea
04/2005

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2015
6Circulating Tumor DNAIBA
01/2020 - 12/2015
4DNA (Deoxyribonucleic Acid)IBA
11/2020 - 10/2015
3AntibodiesIBA
12/2020 - 03/2008
3Immune Checkpoint InhibitorsIBA
01/2020 - 12/2019
3pembrolizumabIBA
01/2020 - 12/2015
3IpilimumabIBA
01/2020 - 06/2014
3Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2008
2Cell-Free Nucleic AcidsIBA
11/2020 - 10/2017
2Biological ProductsIBA
01/2019 - 04/2009
2Phosphotransferases (Kinase)IBA
12/2015 - 02/2010
2VemurafenibIBA
12/2015 - 06/2014
2Adapalene (Differin)FDA LinkGeneric
06/2014 - 09/2012
2SuspensionsIBA
05/2009 - 03/2008
2AntigensIBA
03/2008 - 04/2005
1TropomyosinIBA
12/2020
1AutoantibodiesIBA
12/2020
1Immunoglobulin A (IgA)IBA
12/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020
1Pharmaceutical PreparationsIBA
10/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1Circulating MicroRNAIBA
11/2019
1MicroRNAs (MicroRNA)IBA
11/2019
1LigandsIBA
06/2019
1Conditioned Culture MediaIBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Interleukin-1 (Interleukin 1)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Guanine NucleotidesIBA
12/2018
1Protein Isoforms (Isoforms)IBA
12/2018
1GTP-Binding Proteins (G-Protein)IBA
12/2018
1ParaffinIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1trametinibIBA
12/2015
1NivolumabIBA
12/2015
1dabrafenibIBA
12/2015
1RNA (Ribonucleic Acid)IBA
10/2015
1Dacarbazine (DIC)FDA LinkGeneric
06/2014
1Indicators and Reagents (Reagents)IBA
06/2014
1ErbB Receptors (EGF Receptor)IBA
02/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2010
1tyrosine receptor (receptor, tyrosine)IBA
02/2010
1ChemokinesIBA
05/2009
1Infliximab (Remicade)FDA Link
05/2009
1Immunologic Factors (Immunomodulators)IBA
05/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2009
1CytokinesIBA
05/2009
1Antirheumatic Agents (DMARD)IBA
05/2009
1Rituximab (Mabthera)FDA Link
05/2009
1Hepatitis B e AntigensIBA
03/2008
1VaccinesIBA
03/2008
1Serine (L-Serine)FDA Link
04/2006
1Transcription Factors (Transcription Factor)IBA
04/2006
1PhosphoproteinsIBA
04/2006
1Tyrosine (L-Tyrosine)FDA Link
04/2006
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
04/2006
1Threonine (L-Threonine)FDA Link
04/2006

Therapy/Procedure

12Therapeutics
11/2020 - 05/2009
3Microspheres (Microsphere)
02/2010 - 04/2005
2Immunotherapy
12/2020 - 12/2015